Researcher biography

Dr. Andrew Lai is a leading biotechnologist and translational researcher, specialising in the role of extracellular vesicles (EVs) in gynaecological cancers and reproductive diseases. His research focuses on developing innovative EV isolation methods and characterising EV cargo to discover biomarkers with potential clinical applications.

His work has directly influenced the development of an early-detection test for ovarian cancer, OCRF-7, which is currently being validated for clinical use. His expertise in mass spectrometry-based proteomics has been instrumental in advancing the understanding of EV roles in cancer progression and treatment resistance.